Skip to content

Laboratory Medicine

Test Directory / vWF Antigen Assay

vWF Antigen Assay

Citrate Plasma

TestvWF Antigen Assay
Common AbbreviationsvWF:Ag
Profilevon Willebrand's Disease Screen: vWF:Activity (vWF:RCo/vWF:GP1b) vWF:Antigen (vWF:Ag) vWF:Collagen Binding Assay (vWF:CBA) Factor VIII Assay Coagulation Screen
Clinical IndicationvWF:Ag Assay is used to measure the amount of vWF. Von Willebrand factor (VWF) testing is used to investigate excessive or recurrent bleeding episodes or a personal or family history of excessive bleeding. Testing is used to help diagnose von Willebrand disease (VWD) and distinguish between the various types of VWD. Always used in as part of a vWD Screen
Specimen TypeBlood
Sample TypeCitrate Plasma
Minimum Volumetotal required for a vWD Screen: 3 x 3mL (adult) 3 x 1mL (paed) (citrated plasma must be filled to bottle line)
Special PrecautionsMust state if patient is on anticoagulants (DOAC, Warfarin, Heparin); known coagulation disorders; clincal symptoms (bleeding, bruising).
Stability4-6 hours
Turnaround Time4 hours (urgent) 3 weeks (routine)
LaboratoryYork Hospital
Reference IntervalReference range printed on final report.
LimitationsHaemolysis, gross lipaemia, high haematocrit may interfere with measurement. Over or under filled samples cannot be used due to ratio between blood and citrate
Additional Information
York Hospital's car park.

Getting here

Chinese Poland

View all languages >

Update for visitors

Visiting restrictions are in place at our hospitals to stop the spread of norovirus. These restrictions will be in place until further notice.

The following wards are closed to visitors:

There are four exceptions only to the restrictions. These are:

We understand these restrictions can be difficult when a loved one is unwell. The restrictions will be reviewed daily and lifted as soon as it is safe. Thank you for your understanding as we try to reduce the spread of norovirus in our hospitals.